Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK
Mumbai: Indoco Remedies has announced that its subsidiary company, Indoco Remedies UK Limited, has officially launched Ticagrelor film-coated tablets 90mg in the United Kingdom.
This significant addition to Indoco’s portfolio will be marketed and distributed by Clarity Pharma, across the United Kingdom.
Ticagrelor film-coated tablets are indicated to reduce the chances of heart attack, stroke, myocardial infarction (MI) or diseases related to the heart or blood vessels.
“This development underscores our commitment to bringing high quality, life-saving treatments to patients in the UK”, said Aditi Kare Panandikar, Managing Director, Indoco Remedies Ltd.
Read also: Indoco Remedies Varenicline Tablets gets USFDA nod to aid smoking cessation treatment
Indoco is a fully integrated, research-oriented pharmaceutical company with a global presence. The Company’s turnover is US$ 180 million with a human capital of over 6000 employees, including over 400 skilled scientists and field staff. The Company has 11 manufacturing facilities, 7 for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. The facilities have been approved by most of the Regulatory Authorities including USFDA and UK-MHRA. Indoco develops and manufactures a wide range of pharmaceutical products for the Indian and international markets. It generates more than 106 million prescriptions annually from over 2,40,000 doctors belonging to various specialties.
Read also: Indoco Remedies enters into distribution partnership with Clarity Pharma
Indoco has 10 domestic marketing divisions, a brand portfolio in various therapeutic segments including Gastro-intestinal, Respiratory, Anti-Infectives, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management, Gynaecology, etc. Top Indoco brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Aloja, Glychek, Kidodent, Subitral, Rexidin, MCBM 69, Methycal, Dropizin, Noxa, Homide, Cal-Aid, Ninaf, CitalUti, Otorex, etc. On the international front, Indoco has tie-ups with large generic companies across the globe.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.